Take the Leap - Emilia McLaughlin

In this episode, Naji welcomes Emilia McLaughlin, a biotech founder and CEO, to discuss her journey into the field. Emilia shares that her initial interest in medicine led her to study biochemistry, but she eventually found her passion in parasitology. She describes her shift from academic research to entrepreneurship as motivated by a desire to directly impact patient care, which she found lacking in academic work.
Emilia highlights her experience with the incubator program Entrepreneur First, which catalyzed her transition into biotech entrepreneurship. She emphasizes the importance of building strong teams, hiring the right people, and maintaining a focus on patient needs in the biotech industry. She discusses the challenges of being a female founder in a predominantly male industry and the importance of supporting other women in making the leap from academia to entrepreneurship. Throughout the conversation, Emilia emphasizes the value of bravery and risk-taking in entrepreneurship, particularly for women, and underscores the importance of keeping patients at the forefront of healthcare innovation.
"Nobody has all the answers. You've just got to throw yourself in and do the best you can."
MEET OUR GUEST Emilia McLaughlin ( / emilia-mclaughlin ) , Founder and CEO at Kyron Bio.
Emilia McLaughlin is founder and CEO of kyron.bio (kyron.bio) , a startup based in Paris dedicated to pioneering tomorrow’s therapeutics. Originally from London, Emilia moved to Paris in 2017 to pursue a PhD in parasite molecular biology at the Institut Pasteur. Upon completing her PhD, she founded kyron.bio with the aim of enhancing the efficacy of protein therapeutics through innovative glycan modifications. Since its inception, Emilia has successfully recruited a world-class scientific team, established a state-of-the-art laboratory, secured core technology IP, and garnered over €1.2M in competitive grants from the French government and the EU. Additionally, she has raised €1.1M in equity funding. Currently, the company is testing its first therapeutic in human serum and has developed a robust pipeline of innovative products.
In 2024, Emilia was recognized as a Woman in Leadership by the European Innovation Commission. She is passionate about empowering women to take on leadership roles and supports academics who aspire to transition into entrepreneurship.